Formula & Concentration

[Coagulation Factor IX (Recombinant)]

Manufacturer

Takeda

Indications

RIXUBIS (Coagulation Factor IX [Recombinant]) is an antihemophilic factor indicated in adults and children with hemophilia B for:

  • Control and prevention of bleeding episodes, perioperative management, and routine prophylaxis. (1)

RIXUBIS is not indicated for induction of immune tolerance in patients with Hemophilia B.

Product Options

Package Size

NDC #

Presentation

250 IU

00944-3026-02

Vial

500 IU

00944-3028-02

Vial

1000 IU

00944-3030-02

Vial

2000 IU

00944-3032-02

Vial

3000 IU

00944-3034-02

Vial

Shelf Life and Storage

Store at refrigerated temperature [2°C to 8°C (36°C to 46°F)] or room temperature [not to exceed 30°C (86°F)] for up to 36 months. Do not freeze. Do not use beyond the expiration date printed on the carton or vial.